News Focus
News Focus
icon url

HyGro

09/07/22 7:41 PM

#511854 RE: biosectinvestor #511847

Confounding PFS and OS, new protocol not approved by regulators, company refusal to identify cause of FDA trial partial stop, etc. etc. are all from SEC filings.